Dr. Divya Bajpai 🇮🇳 Profile picture
Prof Nephro KEM, ISOT Council, #NSMC faculty #Visualabstract creator. ISN-Emerging leader Women in Nephro I-Win Creator-monthly #Isneducation quizzes. Mom

Jun 12, 2021, 10 tweets

.@BradRovin speaking on the evolution of #lupus therapy over the years in @isn_india Masterclass
The main change which has happened is to decrease steroids.

Probably 1 gm of MPS is enough to begin treatment in #lupus

Discussing the data on minimizing steroids @BradRovin shows data by @kidneydoc101 which formed the basis of RITUXILUP
Are we going towards NO steroids for #lupus ?

Hope at the end of the tunnel. Positive trials upcoming new Rx for #lupus
Is obinutuzumab better than rituximab

How is #Voclosporin different from CSA?
Less need for TDM monitoring
high potency
low glucose / lipid side effects

.@BradRovin discusses pooled AURA - LV and AURORA trial
Very hopeful results
Check out #visualabstract and summary in @LastNeph Also, soon to be discussed in @NephJC

Subgroup analysis of AURORA
Is it same for all races and all LN Class? pts on MMF had more significant different (can be related to disease severity)

#voclosporin might not be the first choice for pts with severely reduced GFR

Moving to Belimumab - It reduces flares (even in kids) and slows progression to ESKD when added to background therapy

.@BradRovin is very hopeful about Obintuzumab and 2 doses of MPS with MMF might make #lupus pts steroids free!! @kidneydoc101
He is also talking about subtyping pts who have B cell dominant disease to target for these therapies

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling